Big Pharma’s Ails Could Spread To Biotech
It is no secret big drugmakers are sick. Investors should worry that their germs could spread to smaller, hotter biotech stocks.

Financial Snapshot For December
Financial Snapshot For December 2004: Sideways

Facing Biotech Foods Without the Fear Factor
“Almost everywhere food is sold these days, you are likely to find products claiming to contain no genetically modified substances. But unless you are buying wild mushrooms, game, berries or fish, that statement is untrue.”

Big Changes for Big Pharma
Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are six trends that will alter the industry in 2005

Biotechs forced to work harder to fill openings:
Bay Area biotech companies are scrambling to attract and retain both researchers and executives in a cut-throat national and even international job market.

Merck Outlines Vioxx Defense
At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.